Text Message Support to Prevent Smoking Relapse

Tobacco Use Disorder Clinical Trial

Official title:

Text Message Support to Prevent Smoking Relapse in Community Treatment Settings

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02968095
• Other study ID #: K23DA037320
• Secondary ID: K23DA037320
• Status: Completed
• Phase: N/A
• Start date: August 7, 2018
• Est. completion date: August 23, 2019

Study information

• Verified date: November 2019
• Source: Miami University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to test a text message intervention for people who are beginning an attempt to quit smoking. The intervention seeks to teach people to think about their cravings to smoke in more helpful ways. The investigators expect that participants receiving the text message craving program will be less likely to begin smoking again compared to participants in a control condition.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 58
• Est. completion date: August 23, 2019
• Est. primary completion date: August 23, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 or older

• Current daily smoking defined as smoking =5 cigarettes per day and having smoked for at least 3 months. During the first visit smoking status will be verified by a Carbon Monoxide level of at least 8 parts per million.

• Have a mobile phone and use text messaging at least monthly

• Be planning to quit smoking without pharmacological help.

Exclusion Criteria:

• Significant cognitive impairment

• Current therapy or pharmacological intervention for smoking or nicotine cravings

• Inability to read English

Related Conditions & MeSH terms

• Tobacco Use Disorder

Intervention

Behavioral:
• Text Message Craving Program
Text messages targeting cravings delivered 2-3 times per day.
• Self-Help Manual Plus Control Texts
Self-help manual plus motivational text messages delivered 2-3 times per day.

Locations

Country	Name	City	State
United States	Miami University	Oxford	Ohio

Sponsors (3)

Lead Sponsor	Collaborator
Miami University	National Institute on Drug Abuse (NIDA), University of Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	7-Day Point Prevalence Abstinence	Point prevalence abstinence is defined as the prevalence of not experiencing a full relapse in the period immediately preceding measurement. A full relapse will be defined as 7 continuous days of smoking or smoking = 1 day(s) per week for the two consecutive weeks preceding the time of measurement. Self-reported abstinence will be verified by a Carbon Monoxide assay of breath samples and will override self-report in the direction of smoking.	End of Treatment (6-week) Follow-Up